The 5th Golden Helix Pharmacogenomics day was held in the Mikiel Anton Vassalli Conference Centre, Gateway Building, Hall E of the University of Malta in Msida, Malta. Over 150 registered participants have attended this meeting, in which the European Commissioner for Health and Consumer Policy, Dr. John Dalli gave an opening lecture.
Co-organized by: Under the auspices of:
IntroductionSpeakersScientific ProgramSponsorsGalleryThe 5th Golden Helix Pharmacogenomics day was held in the Mikiel Anton Vassalli Conference Centre, Gateway Building, Hall E of the University of Malta in Msida, Malta. Over 150 registered participants have attended this meeting, in which the European Commissioner for Health and Consumer Policy, Dr. John Dalli gave an opening lecture.
Co-organized by: Under the auspices of:
Organizing Committe
Anthony G Fenech; Senior Lecturer, Department of Clinical Pharmacology and Therapeutics, University of Malta
Godfrey Grech; Senior Lecturer, Department of Pathology, University of Malta
Joseph Borg; Lecturer, Department of Applied Biomedical Sciences, University of Malta
George P. Patrinos; Assistant Professor, Department of Pharmacy, University of Patras, Greece
Invited speakers
Christian Scerri (Msida, Malta)
Ron van Schaik (Rotterdam, the Netherlands)
Marisa Papaluca-Amati (London, UK)
Jean-Luc Sanne (Brussels, Belgium)
Laura Uribe (Singapore, Singapore)
George P Patrinos (Patras, Greece)Anthony G Fenech (Msida, Malta)Godfrey Grech (Msida, Malta)
Andrew Webb (Manchester, UK)
Gustav Karlberg (Chesterfield, UK)
Alessio Squassina Cagliari, Italy)
Joseph Borg (Msida, Malta)
Scientific Program
08.30 09.00 Registration
Opening addresses
09.00 09.10 Commissioner John Dalli, European Commissioner for Health and Consumer Policy
09.10 09.20 Paul Zahra,Acting PErmanent Secretary, Ministry for Health, the Elderly and Community Care
09.20 09.30Godfrey LaFerla, Professor of Surgery, Dean, Faculty of Medicine and Surgery, University of Malta
Session 1 – Chairpersons: Roger Ellul-Micallef, Bridget Ellul
09.30 09.50 Christian Scerri, Consultant clinical geneticist, Mater Dei Hospital; Associate Professor, University of Malta
The opportunities that an island population can offer to pharmacogenomics
09.50 10.10 Ron van Schaik, Associate Professor, Erasmus MC, Department of Clinical Chemistry, Rotterdam, the Netherlands
Clinical implementation of pharmacogenetics: a 6 year experience
Coffee Break
10.40 11.00 Marisa Papaluca Amati, Human Medicines Development and Evaluation Unit, Scientific Support and Projects, European Medicines Agency, London, UK
Genomic and personalised medicines: how can regulators contribute? [videoconferenced]
11.00 11.20 Jean-Luc Sanne, Directorate General for Health, European Commission, Brussels, Belgium
Personalised medicine in the FP7 Health priority
11.20 11.50 Company Lecture – Laura Uribe, Clinical applications Manager, International Markets, Affymetrix, Singapore
Comprehensive analysis of pharmacogenomic variants with the DMET Plus panel
Keynote lecture
11.50 12.30 George P Patrinos, Assistant Professor, University of Patras, Department of Pharmacy, Patras, Greece
Pharmacogenomics and personalized medicine
Lunch break
Session 2 – Chairpersons: Alexander Felice, Janet Mifsud
13.30 14.00 Anthony G Fenech, Senior Lecturer, Department of Clinical Pharmacology and Therapeutics, University of Malta; Godfrey Grech, Senior Lecturer, Department of Pathology, University of Malta
Molecular aspects of pharmacogenomics
14.00 14.30 Company Lecture – Andrew Webb, Senior Director, Head of Personalized Healthcare, Global Market Development, Qiagen Manchester Ltd, UK
Personalized healthcare The new clinical paradigm
14.30 15.00 Company Lecture – Gustav Karlberg, Marketing Manager Europe, Illumina Ltd, UK
Illumina Next Generation Sequencing and arrays: Applications in pharmacogenomics
15.00 15.30 Alessio Squassina, Research Associate, Department of Neuroscience,University of Cagliari; Joseph Borg, Lecturer, Department of Applied Biomedical Sciences, University of Malta
Pharmacogenomic application in the management of classical and complex disorders
15.30 16.00 Concluding remarks
Sponsors
The Organizing Committee acknowledges the support of following entities that supported the organization of the 5th Golden Helix Pharmacogenomics Day:
Sponsors:
Supporters:
